Potential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial Dysfunction

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00001531

Enrollment

355

Registered

2002-12-10

Start date

1996-06-30

Completion date

2000-09-30

Last updated

2008-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arterial Occlusive Diseases, Atherosclerosis, Coronary Disease, Cytomegalovirus Infections

Keywords

Atherogenesis, Cell Mediated Immunity, Coronary Artery Disease

Brief summary

The purpose of this study is to investigate whether the susceptibility of subjects to atherosclerosis is influenced by prior CMV exposure, whether the susceptability to endothelial dysfunction in patients with and in patients without atherosclerosis is influenced by prior CMV exposure.

Detailed description

Interventions

None listed

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

Patients who are being evaluated to determine if they have CAD or those who have already been studied and the presence or absence of CAD has been ascertained. No patients who have not been evaluated for CAD.

Countries

United States

Outcome results